What it tells you is that major share holders are lining up with shares. Second human dosing is coming up shortly and AGN results are exactly 3 months away. Within 3 months NYR will not only prove up safety but AGN will prove up the mechanism of action that inhibiting calcium influx in the brain provides brain protection. This 20 million market cap is funny things will change and the upside of the company will be in line with its peers.
NYR Price at posting:
11.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)